15 results
8-K
EX-10.1
URGN
UroGen Pharma Ltd.
8 Aug 24
Departure of Directors or Certain Officers
4:30pm
: (a) to promote the Company’s mission, long term goals and targets; (b) to create appropriate incentives for the Company’s directors and officers with the aim … of aligning such directors’ and officers’ compensation with the Company’s mission and goals, taking into account, among other things, the compensation
10-K/A
2022 FY
URGN
UroGen Pharma Ltd.
1 May 23
Annual report (amended)
4:37pm
efforts in support of advancing its mission until his departure in August 2021. Prior to joining Strides Pharma, Mr. Kim was Controller at Sun Pharma Inc
8-K
EX-99.1
a2rbsr98
10 May 22
UroGen Pharma Reports First Quarter 2022 Financial Results
9:11am
8-K
1n77wzk4ystchs7gk
21 Mar 22
UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results
8:11am
8-K
EX-99.1
cpvn 7clvl
13 May 21
UroGen Pharma Reports First Quarter 2021 Financial Results and Recent Corporate Developments
7:40am
8-K
EX-99.1
959 qec1tbksdud10ko
18 Mar 21
UroGen Pharma Announces $75 Million of Non-Dilutive Funding from RTW Investments
8:10am
8-K
EX-99.1
ciyieuhdv8
9 Nov 20
UroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate Developments
8:13am
DEF 14A
gm3tecnkm v0kyobea
26 Apr 19
Definitive proxy
5:00pm
- Prev
- 1
- Next